Evidence map›Paper›PMID 23740248›Full record

ArticleThe Journal of biological chemistry2013

SLLISWD sequence in the 10FNIII domain initiates fibronectin fibrillogenesis.

Elaine P S Gee, Deniz Yüksel, Collin M Stultz, Donald E Ingber

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Stressed podocytes-mechanical forces, sensors, signaling and response.Pflugers Archiv : European journal of physiology · 2017
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Cryptic activity within the Type IIICurrent topics in peptide & protein research
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elaine P S GeeFrom the Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts 02115.
Deniz YükselFrom the Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts 02115,; the Vascular Biology Program and Departments of Pathology and Surgery, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts 02115.
Collin M Stultzthe Institute of Medical Engineering and Sciences, Department of Electrical Engineering and Computer Science, and the Research Laboratory of Electronics, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, and.
Donald E IngberFrom the Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts 02115,; the Vascular Biology Program and Departments of Pathology and Surgery, Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts 02115,; the Harvard School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts 02138. Electronic address: don.ingber@wyss.harvard.edu.

Funding

TUMOR DORMANCY INDUCED BY BLOCKED ANGIOGENESISP01CA045548 · NCI · CHILDREN'S HOSPITAL BOSTON · PI FOLKMAN, JUDAH · 1987 to 2011
$22.6M
NCI NIH HHS P01 CA045548
6 · The paper itself

Abstract

Fibronectin (FN) assembly into extracellular matrix is tightly regulated and essential to embryogenesis and wound healing. FN fibrillogenesis is initiated by cytoskeleton-derived tensional forces transmitted across transmembrane integrins onto RGD binding sequences within the tenth FN type III (10FNIII) domains. These forces unfold 10FNIII to expose cryptic FN assembly sites; however, a specific sequence has not been identified in 10FNIII. Our past steered molecular dynamics simulations modeling 10FNIII unfolding by force at its RGD loop predicted a mechanical intermediate with a solvent-exposed N terminus spanning the A and B β-strands. Here, we experimentally confirm that the predicted 23-residue cryptic peptide 1 (CP1) initiates FN multimerization, which is mediated by interactions with 10FNIII that expose hydrophobic surfaces that support 8-anilino-1-napthalenesulfonic acid binding. Localization of multimerization activity to the C terminus led to the discovery of a minimal 7-amino acid "multimerization sequence" (SLLISWD), which induces polymerization of FN and the clotting protein fibrinogen in addition to enhancing FN fibrillogenesis in fibroblasts. A point mutation at Trp-6 that reduces exposure of hydrophobic sites for 8-anilino-1-napthalenesulfonic acid binding and β-structure formation inhibits FN multimerization and prevents physiological cell-based FN assembly in culture. We propose a model for cell-mediated fibrillogenesis whereby cell traction force initiates a cascade of intermolecular exchange starting with the unfolding of 10FNIII to expose the multimerization sequence, which interacts with strand B of another 10FNIII domain via a Trp-mediated β-strand exchange to stabilize a partially unfolded intermediate that propagates FN self-assembly.

Indexed as

Protein MultimerizationAmino Acid SequenceCells, CulturedExtracellular MatrixFibrinogenFibroblastsFibronectinsHumansHydrophobic and Hydrophilic InteractionsModels, MolecularMolecular Sequence DataPeptide FragmentsPeptidesPolymerizationProtein BindingProtein Structure, SecondaryanastellinFibrinogenFibronectinsPeptide FragmentsPeptidesTryptophanAnastellinComputer ModelingCryptic SitesExtracellular MatrixMechanobiologyPeptidesProtein Cross-linkingProtein Self-assemblyRGD

Identifiers

PMID23740248
PMCPMC3774401

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.